Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eptifibatide-Facilitated PCI vs Primary PCI in STEMI
NCT00251823Phase 3Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Jul 2005
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of eptifibatide in myocardial infarction (MI) (2 arms), sponsored by University of Ottawa Heart Institute. Primary endpoint: Composite of death, recurrent myocardial infarction, and recurrent severe ischemia at 30 days. Started Jul 2005; status: completed.
02
Drugs
eptifibatide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00251823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251823.